Session V: Oral Presentations


Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients

C. Oreja-Guevara

COVID-19 in Multiple Sclerosis Patients in Dubai: Observational Study

M. Thakre

Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients

A. Dahshan

Radiologically Isolated Syndrome Conversion to Multiple Sclerosis

F. Sabeti

Serum Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

H. K. Hassoun

Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study

B. Yamout